Amitiza
NDC 23635-524, lubiprostone, capsule, gelatin coated, from SpecGx LLC.
- Product NDC
- 23635-524
- Status
- Listed
- Labeler
- SpecGx LLC
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021908
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/23635-524 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LUBIPROSTONE24 ug/1
Pharmacologic classes
Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 23635-524-60 | 23635052460 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (23635-524-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/164a2b47-0a52-4bb4-9e71-5342c2e951f4NADAC price for package 23635052460
GET /v1/drugs/nadac/23635052460
Use it
Look up 23635-524 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/23635-524 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 23635-524. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.